SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK (STOP-SHOCK)

Universitätsklinikum Hamburg-Eppendorf

Status: Enrolling

Conditions: Cardiogenic Shock

Study type: Observational

Funder types: Other

Identifiers

NCT03313687

STOP-SHOCK

Details and patient eligibility

About

International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.

Full description

There is a focus on interventional therapies, mechanical circulatory support and new cardiovascular therapeutics in patients with cardiogenic shock (CS). The investigators will describe current practice in study sites including concomitant patients with CS. Therefore, the investigators will monitor drug therapies initiated, devices being utilized as well as outcome and side effect of possible interventions

Enrollment: 2,500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with cardiogenic shock treated at a tertiary care hospital.

Exclusion criteria

• Age ≤17 years.